The Kadin article reviewed. The importance of accurately characterizing lymphoproliferative disease.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Works matching IS 08909091 AND DT 2009 AND VI 23 AND IP 13
Results: 21
1
2
The Selvaggi/Scagliotti article reviewed. Histology... for want of anything better?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
3
Subdividing NSCLC: reflections on the past, present, and future of lung cancer therapy.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
4
Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
5
Integrative oncology: complementary therapies, herbs, and other OTC agents. Oxygen therapies.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
6
CME post-test.
- Published in:
- 2009
- Publication type:
- Journal Article
7
The Dmytrijuk/Robie-Suh/Rieves et al article reviewed. Update on eltrombopag for ITP.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
8
Histologic subtype in NSCLC: does it matter?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
9
Peripheral T-cell lymphomas: their time has come.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
10
Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
11
Peripheral T-cell Lymphomas: Their Time Has Come.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 13, p. 1151
- By:
- Publication type:
- Article
12
The Kadin article reviewed. Diagnostic and therapeutic challenges of primary cutaneous lymphomas.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
13
The Importance of Accurately Characterizing Lymphoproliferative Disease.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 13, p. 1168
- By:
- Publication type:
- Article
14
Update on Eltrombopag for ITP.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 13, p. 1177
- By:
- Publication type:
- Article
15
Current Management of Primary Cutaneous CD3O+ T-cell Lymphoproliferative Disorders.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 13, p. 1158
- By:
- Publication type:
- Article
16
Oxygen Therapies.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 13, p. 1182
- By:
- Publication type:
- Article
17
Eltrombopag for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 13, p. 1171
- By:
- Publication type:
- Article
18
Diagnostic and Therapeutic Challenges of Primary Cutaneous Lymphomas.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 13, p. 1167
- By:
- Publication type:
- Article
19
Subdividing NSC LC: Reflections on the Past, Present, and Future of Lung Cancer Therapy.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 13, p. 1147
- By:
- Publication type:
- Article
20
Histology... For Want of Anything Better?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 13, p. 1140
- By:
- Publication type:
- Article
21
Histologic Subtype in NSCLC: Does It Matter?
- Published in:
- Oncology (08909091), 2009, v. 23, n. 13, p. 1133
- By:
- Publication type:
- Article